Thomas M Moriarty
CIK 1412221 · EVP, M&A and Corporate Affairs · last filed 2026-08-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$51.92M
Companies
4
Total Filings
76
Lifetime Open-Market Net
-$73.28M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACI | EVP, M&A and Corporate Affairs | 617,892 | $12.12 | $7.49M | $1.96M | 26 | 2026-08-11 |
| CVS | EVP & General Counsel | 474,393 | $93.65 | $44.43M | -$66.46M | 30 | 2023-01-04 |
| CELGENE CORP /DE/ (CELGZ) Delisted | see remarks | — | — | — | $0 | 1 | 2012-06-05 |
| MEDCO HEALTH SOLUTIONS INC (MHS) Delisted | Gen'l Counsel & Secretary, SVP | 0 | — | — | -$8.78M | 19 | 2012-04-03 |
Recent Filings · Page 5 of 8
76 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-03 | CVS | Mixed | −1,806 | -$105.4K | EDGAR |
| 2020-03-03 | CVS | Mixed | +18,226 | $1.08M | EDGAR |
| 2019-04-03 | CVS | Mixed | −4,837 | -$262.1K | EDGAR |
| 2019-03-01 | CVS | Mixed | +4,749 | $274.6K | EDGAR |
| 2018-04-03 | CVS | Mixed | −4,629 | -$288.0K | EDGAR |
| 2018-03-02 | CVS | Grant (A) | +4,650 | $314.9K | EDGAR |
| 2017-10-03 | CVS | Mixed | — | -$1.67M | EDGAR |
| 2017-09-12 | CVS | Mixed | — | -$2.50M | EDGAR |
| 2017-04-04 | CVS | Mixed | +13,398 | $1.04M | EDGAR |
| 2017-03-02 | CVS | Grant (A) | +15,512 | $1.25M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.